PEN
Ticker
Penumbra Inc
Company
Devices
Industry
Healthcare
Sector
2013
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
41.3%48.3%41.5%26.8%33.3%23.0%2.4%33.4%13.3%25.0%12.9% 14.6%
Revenue Growth QoQ
Gross Margin
65.1%66.0%66.7%64.9%65.1%65.7%68.0%60.3%63.6%63.2%64.5%63.2% 66.8%
EBITDA Margin
-0.5%3.0%3.2%0.4%1.5%1.2%10.2%-4.6%1.2%3.6%9.5%2.8% 14.3%
Operating Margin
-1.3%2.4%2.2%-0.5%0.3%-0.2%8.7%-6.9%-1.0%0.7%6.9%0.8% 13.0%
Profit Margin
4.6%1.8%1.3%5.6%1.4%1.5%8.9%-2.8%0.7%-0.2%8.6%1.2% 12.3%
FCF / EBITDA
934.1%-273.3%-467.9%-2792.2%3.2%361.3%8.2%222.6%-131.1%-246.6%81.5%446.6% 80.2%